Infusion of autologous buffy coat cells for CGL in transformation

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Leukemia·2026

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Leukemia·2016

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Leukemia·2016

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.

Leukemia·2012

13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia.

Leukemia·2010

ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis.

Cytometry. Part B, Clinical cytometry·2006

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Lancet (London, England)·2026

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Lancet (London, England)·2026

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Lancet (London, England)·2026

Advances in MOF-Based Transdermal Drug Delivery Systems: Mechanisms, Applications, and Future Prospects.

Topics in current chemistry (Cham)·2026

Development and evaluation of 68Ga-DOTA-EP-1: A novel PET tracer targeting EpCAM for malignant tumor diagnosis.

Bioorganic chemistry·2026

An evaluation of denecimig for bleeding prophylaxis in hemophilia A.

Expert opinion on biological therapy·2026

Thyroid Artery Embolization: A Review and Considerations for the Interventional Radiologist.

Seminars in interventional radiology·2026

Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.

Frontiers in pharmacology·2026

Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017-2019.

Open forum infectious diseases·2026

Related Experiment Videos

Infusion of autologous buffy coat cells for CGL in transformation

Related Concept Videos

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.

13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia.

ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis.

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Advances in MOF-Based Transdermal Drug Delivery Systems: Mechanisms, Applications, and Future Prospects.

Development and evaluation of 68Ga-DOTA-EP-1: A novel PET tracer targeting EpCAM for malignant tumor diagnosis.

An evaluation of denecimig for bleeding prophylaxis in hemophilia A.

Thyroid Artery Embolization: A Review and Considerations for the Interventional Radiologist.

Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.

Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017-2019.

Related Experiment Videos

Infusion of autologous buffy coat cells for CGL in transformation

Related Concept Videos

Related Articles